Bibliographic Info
GuidelineGuidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
Year of Publication2015
Issuing InstitutionWorld Health Organization
Recommendation
Status
Maintained
Recommended in favor
Strong
Certainty of evidence
Moderate
FIRST-LINE ANTIVIRAL THERAPIES FOR CHRONIC HEPATITIS B. In HBV/HIV-coinfected adults, adolescents and children aged 3 years or older, tenofovir + lamivudine (or emtricitabine) + efavirenz as a fixed-dose combination is recommended as the preferred option to initiate antiretroviral therapy (ART)
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations
Year2014
InstitutionWHO
Guideline
Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations
Year2016
InstitutionWHO